RESOURCES

Explore resources from the Value of Care Coalition and its partners.

2020 K Street NW, Suite 505
Washington, DC 20006

2020 K Street NW, Suite 505
Washington, DC 20006

A recent survey of independent pharmacists should serve as a warning about the unintended consequences of upper payment limits.

Colorado and Maryland Prescription Drug Affordability Boards are both in the process of considering how to set upper payment limits.

Two states now seem to be in a race to implement processes for setting upper payment limits.

On Friday, August 9, the Maryland Prescription Drug Affordability Board released its draft Upper Payment Limit Action Plan.

Health care payers are intensely focused on the cost of healthcare, particularly pharmaceutical costs.

Some states are trying to lower health care costs by establishing review boards to assess and limit prescription drug spending.

Who should make decisions about the value of YOUR health? You and your doctor? Or your state government?

States want to lower health care spending. But some policy approaches overlook what matters to patients & health care providers.

Some policy approaches overlook what matters most to patients and providers.

State government-run organizations that make recommendations about a drug’s value don’t always listen to patients and providers.

2020 K Street NW, Suite 505
Washington, DC 20006

2020 K Street NW, Suite 505
Washington, DC 20006